Three-dimensional extracellular matrix culture models of EGFR signalling and drug response

P. A. Kenny

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Three-dimensional extracellular matrix culture, on substrata such as Matrigel, restores many aspects of the differentiated state to non-malignant cells from a variety of tissues. We have adapted these techniques to study EGFR (epidermal growth factor receptor) signalling and drug response in breast cancer cell lines. EGFR-dependent breast cancer cell lines undergo a striking reversion of the malignant phenotype upon treatment with inhibitors targeting the receptor, or downstream signalling intermediates such as mitogen-activated protein kinase and PI3K (phosphoinositide 3-kinase). Using this approach, we have recently reported that EGFR signalling in breast cancer can be effectively inhibited by blocking the activity of a key protease, TACE [TNFα (tumour necrosis factor α)-converting enzyme], which regulates the bioavailability of EGFR ligands. These results suggest a new way to target EGFR signalling in tumours of the breast and other epithelial tissues and underline the value of three-dimensional extracellular matrix culture models for exploring cancer-relevant signalling processes ex vivo.

Original languageEnglish (US)
Pages (from-to)665-668
Number of pages4
JournalBiochemical Society Transactions
Volume35
Issue number4
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Extracellular Matrix
Breast Neoplasms
Pharmaceutical Preparations
MAP Kinase Kinase 3
Cells
Tissue
Cell Line
1-Phosphatidylinositol 4-Kinase
Phosphatidylinositols
Mitogen-Activated Protein Kinases
Biological Availability
Tumors
Peptide Hydrolases
Phosphotransferases
Epithelium
Tumor Necrosis Factor-alpha
Ligands
Phenotype
Enzymes

Keywords

  • Breast cancer cell line
  • Drug response
  • Epidermal growth factor receptor (EGFR)
  • Three-dimensional extracellular matrix culture
  • Tumour necrosis factor α (TNFα)
  • Tumour necrosis factor α-converting enzyme (TACE)

ASJC Scopus subject areas

  • Biochemistry

Cite this

Three-dimensional extracellular matrix culture models of EGFR signalling and drug response. / Kenny, P. A.

In: Biochemical Society Transactions, Vol. 35, No. 4, 08.2007, p. 665-668.

Research output: Contribution to journalArticle

@article{eb87e4ec5ca7454f8ca96c0a9d8132ef,
title = "Three-dimensional extracellular matrix culture models of EGFR signalling and drug response",
abstract = "Three-dimensional extracellular matrix culture, on substrata such as Matrigel, restores many aspects of the differentiated state to non-malignant cells from a variety of tissues. We have adapted these techniques to study EGFR (epidermal growth factor receptor) signalling and drug response in breast cancer cell lines. EGFR-dependent breast cancer cell lines undergo a striking reversion of the malignant phenotype upon treatment with inhibitors targeting the receptor, or downstream signalling intermediates such as mitogen-activated protein kinase and PI3K (phosphoinositide 3-kinase). Using this approach, we have recently reported that EGFR signalling in breast cancer can be effectively inhibited by blocking the activity of a key protease, TACE [TNFα (tumour necrosis factor α)-converting enzyme], which regulates the bioavailability of EGFR ligands. These results suggest a new way to target EGFR signalling in tumours of the breast and other epithelial tissues and underline the value of three-dimensional extracellular matrix culture models for exploring cancer-relevant signalling processes ex vivo.",
keywords = "Breast cancer cell line, Drug response, Epidermal growth factor receptor (EGFR), Three-dimensional extracellular matrix culture, Tumour necrosis factor α (TNFα), Tumour necrosis factor α-converting enzyme (TACE)",
author = "Kenny, {P. A.}",
year = "2007",
month = "8",
language = "English (US)",
volume = "35",
pages = "665--668",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "4",

}

TY - JOUR

T1 - Three-dimensional extracellular matrix culture models of EGFR signalling and drug response

AU - Kenny, P. A.

PY - 2007/8

Y1 - 2007/8

N2 - Three-dimensional extracellular matrix culture, on substrata such as Matrigel, restores many aspects of the differentiated state to non-malignant cells from a variety of tissues. We have adapted these techniques to study EGFR (epidermal growth factor receptor) signalling and drug response in breast cancer cell lines. EGFR-dependent breast cancer cell lines undergo a striking reversion of the malignant phenotype upon treatment with inhibitors targeting the receptor, or downstream signalling intermediates such as mitogen-activated protein kinase and PI3K (phosphoinositide 3-kinase). Using this approach, we have recently reported that EGFR signalling in breast cancer can be effectively inhibited by blocking the activity of a key protease, TACE [TNFα (tumour necrosis factor α)-converting enzyme], which regulates the bioavailability of EGFR ligands. These results suggest a new way to target EGFR signalling in tumours of the breast and other epithelial tissues and underline the value of three-dimensional extracellular matrix culture models for exploring cancer-relevant signalling processes ex vivo.

AB - Three-dimensional extracellular matrix culture, on substrata such as Matrigel, restores many aspects of the differentiated state to non-malignant cells from a variety of tissues. We have adapted these techniques to study EGFR (epidermal growth factor receptor) signalling and drug response in breast cancer cell lines. EGFR-dependent breast cancer cell lines undergo a striking reversion of the malignant phenotype upon treatment with inhibitors targeting the receptor, or downstream signalling intermediates such as mitogen-activated protein kinase and PI3K (phosphoinositide 3-kinase). Using this approach, we have recently reported that EGFR signalling in breast cancer can be effectively inhibited by blocking the activity of a key protease, TACE [TNFα (tumour necrosis factor α)-converting enzyme], which regulates the bioavailability of EGFR ligands. These results suggest a new way to target EGFR signalling in tumours of the breast and other epithelial tissues and underline the value of three-dimensional extracellular matrix culture models for exploring cancer-relevant signalling processes ex vivo.

KW - Breast cancer cell line

KW - Drug response

KW - Epidermal growth factor receptor (EGFR)

KW - Three-dimensional extracellular matrix culture

KW - Tumour necrosis factor α (TNFα)

KW - Tumour necrosis factor α-converting enzyme (TACE)

UR - http://www.scopus.com/inward/record.url?scp=34548189041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548189041&partnerID=8YFLogxK

M3 - Article

C2 - 17635116

AN - SCOPUS:34548189041

VL - 35

SP - 665

EP - 668

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 4

ER -